These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38926074)

  • 21. Corrigendum to "4-Hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice" [Int. Immunopharmacol. 83 (2020) 106445].
    Wang H; Wei X; Wei X; Sun X; Huang X; Liang Y; Xu W; Zhu X; Lin X; Lin J
    Int Immunopharmacol; 2020 Sep; 86():106722. PubMed ID: 32593975
    [No Abstract]   [Full Text] [Related]  

  • 22. Corrigendum to "Asiatic acid inhibits LPS-induced inflammatory response in human gingival fibroblasts" [Int. Immunopharmacol. 50(2017) 313-318].
    Hao C; Wu B; Hou Z; Xie Q; Liao T; Wang T; Ma D
    Int Immunopharmacol; 2019 Jul; 72():523. PubMed ID: 31080023
    [No Abstract]   [Full Text] [Related]  

  • 23. Corrigendum to "Asiatic acid from Potentilla chinensis alleviates non-alcoholic fatty liver by regulating endoplasmic reticulum stress and lipid metabolism". [Int. Immunopharmacol. 65 (2018) 256-267].
    Wang D; Lao L; Pang X; Qiao Q; Pang L; Feng Z; Bai F; Sun X; Lin X; Wei J
    Int Immunopharmacol; 2020 Jul; 84():106291. PubMed ID: 32094005
    [No Abstract]   [Full Text] [Related]  

  • 24. Corrigendum to "MEGF6 prevents sepsis-induced acute lung injury in mice" [Int. Immunopharmacol. 123 (2023) 110727].
    Liang H; Liu G; Zeng W; Fan Q; Nie Z; Hu H; Zhang R; Xie S
    Int Immunopharmacol; 2024 May; 133():111787. PubMed ID: 38641473
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiplatelet activities of newly synthesized derivatives of piperlongumine.
    Park BS; Son DJ; Choi WS; Takeoka GR; Han SO; Kim TW; Lee SE
    Phytother Res; 2008 Sep; 22(9):1195-9. PubMed ID: 18697182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corrigendum to "Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis" [Int. Immunopharmacol. 99 (2021) 108005].
    Mohamed NI; Suddek GM; El-Kashef DH
    Int Immunopharmacol; 2022 Apr; 105():108575. PubMed ID: 35115257
    [No Abstract]   [Full Text] [Related]  

  • 27. Corrigendum to "Intravenous immunoglobulin alleviates Japanese encephalitis virus-induced peripheral neuropathy by inhibiting the ASM/ceramide pathway" [Int. Immunopharmacol. 133 (2024) 112083].
    Zhang N; Wang G; Yang L; Zhang J; Yuan Y; Ma L; Wang H; Wang Z
    Int Immunopharmacol; 2024 Jun; 134():112270. PubMed ID: 38762402
    [No Abstract]   [Full Text] [Related]  

  • 28. Corrigendum to "Atorvastatin calcium alleviates 5-fluorouracil-induced intestinal damage by inhibiting cellular senescence and significantly enhances its antitumor efficacy" [Int. Immunopharmacol. 121 (2023) 110465].
    Xia J; He S; Dai Q; Jia H; Ge Y; Zhou M; Wang XB
    Int Immunopharmacol; 2023 Aug; 121():110620. PubMed ID: 37455170
    [No Abstract]   [Full Text] [Related]  

  • 29. Corrigendum to "Isosteroid alkaloids with different chemical structures from Fritillariae cirrhosae bulbus alleviate LPS-induced inflammatory response in RAW 264.7 cells by MAPK signaling pathway" [Int. Immunopharmacol. 78 (2020) 106047].
    Liu S; Yang T; Ming TW; Gaun TKW; Zhou T; Wang S; Ye B
    Int Immunopharmacol; 2020 Jul; 84():106482. PubMed ID: 32278661
    [No Abstract]   [Full Text] [Related]  

  • 30. Corrigendum to "Erastin enhances metastatic potential of ferroptosis-resistant ovarian cancer cells by M2 polarization through STAT3/IL-8 axis". [Int. Immunopharmacol. 113(Pt B) (2022) 109422].
    Cang W; Wu A; Gu L; Wang W; Tian Q; Zheng Z; Qiu L
    Int Immunopharmacol; 2024 Mar; 129():111651. PubMed ID: 38365538
    [No Abstract]   [Full Text] [Related]  

  • 31. Crystal structures of three 1-[4-(4-bromo-but-oxy)-phen-yl] chalcone derivatives: (
    Maragatham G; Selvarani S; Rajakumar P; Lakshmi S
    Acta Crystallogr E Crystallogr Commun; 2017 Jul; 73(Pt 8):1232-1236. PubMed ID: 28932443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corrigendum to "Evaluation of the immunomodulatory and anti-inflammatory activity of Bakuchiol using RAW 264.7 macrophage cell lines and in animal models stimulated by lipopolysaccharide (LPS)" [Int. Immunopharmacol. 91 (2021) 107264].
    Kumar A; Sawhney G; Kumar Nagar R; Chauhan N; Gupta N; Kaul A; Ahmed Z; Sangwan PL; Satheesh Kumar P; Yadav G
    Int Immunopharmacol; 2022 Oct; 111():109003. PubMed ID: 35778365
    [No Abstract]   [Full Text] [Related]  

  • 33. Corrigendum to "Maclurin inhibits caspase-11 non-canonical inflammasome in macrophages and ameliorates acute lethal sepsis in mice" [Int. Immunopharmacol. 129 (2024) 111615].
    Lee DJ; Lee SY; Yi YS
    Int Immunopharmacol; 2024 May; 132():111969. PubMed ID: 38575463
    [No Abstract]   [Full Text] [Related]  

  • 34. 1H and 13C NMR spectral assignments of novel chromenylchalcones.
    Yoon H; Ahn S; Hwang D; Jo G; Kim DW; Kim SH; Koh D; Lim Y
    Magn Reson Chem; 2012 Nov; 50(11):759-64. PubMed ID: 22961709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corrigendum to "RNF125, transcriptionally regulated by NFATC2, alleviates osteoarthritis via inhibiting the Wnt/β-catenin signaling pathway through degrading TRIM14" [Int. Immunopharmacol. 125 (2023) 111191].
    Lv R; Du L; Bai L
    Int Immunopharmacol; 2024 Jan; 127():111425. PubMed ID: 38142206
    [No Abstract]   [Full Text] [Related]  

  • 36. Corrigendum to "BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia-reperfusion" [Int. Immunopharmacol. 119 (2023) 110201].
    Guo K; Shang Y; Wang Z; Li Y; Chen J; Zhu B; Zhang D; Chen J
    Int Immunopharmacol; 2024 Mar; 129():111541. PubMed ID: 38302345
    [No Abstract]   [Full Text] [Related]  

  • 37. Corrigendum to "Gypenoside XLIX attenuates sepsis-induced splenic injury through inhibiting inflammation and oxidative stress" [Int. Immunopharmacol. 127 (2024) 111420].
    Xu B; Yang R; Qiang J; Xu X; Zhou M; Ji X; Lu Y; Dong Z
    Int Immunopharmacol; 2024 Apr; 131():111694. PubMed ID: 38368241
    [No Abstract]   [Full Text] [Related]  

  • 38. Corrigendum to "STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance" [Int. Immunopharmacol. 119 (2023) 110160].
    Gharibi T; Barpour N; Hosseini A; Mohammadzadeh A; Marofi F; Ebrahimi-Kalan A; Nejati-Koshki K; Abdollahpour-Alitappeh M; Safaei S; Baghbani E; Baradaran B
    Int Immunopharmacol; 2023 Jun; 119():110303. PubMed ID: 37179201
    [No Abstract]   [Full Text] [Related]  

  • 39. Corrigendum to "Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-κB" [Int. Immunopharmacol. 101(Part B) (2021) 108290].
    Zhu Y; Ruan S; Shen H; Guan Q; Zhai L; Yang Y
    Int Immunopharmacol; 2023 Jun; 119():110302. PubMed ID: 37193623
    [No Abstract]   [Full Text] [Related]  

  • 40. Corrigendum to "MicroRNA-208-5p regulates myocardial injury of sepsis mice via targeting SOCS2-mediated NF-κB/HIF-1α pathway" [Int. Immunopharmacol. 81 (2020) 106204].
    Ouyang H; Tan Y; Li Q; Xia F; Xiao X; Zheng S; Lu J; Zhong J; Hu Y
    Int Immunopharmacol; 2022 Mar; 104():108355. PubMed ID: 35058156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.